Skip to main content
Article thumbnail
Location of Repository

In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development

By Masahiro Goto, Karen Piper Piper Hanley, Josep Marcos, Peter J. Wood, Sarah Wright, Anthony D. Postle, Iain T. Cameron, J. Ian Mason, David I. Wilson and Neil A. Hanley

Abstract

In humans, sexual differentiation of the external genitalia is established at 7–12 weeks post conception (wpc). During this period, maintaining the appropriate intrauterine hormone environment is critical. In contrast to other species, this regulation extends to the human fetal adrenal cortex, as evidenced by the virilization that is associated with various forms of congenital adrenal hyperplasia. The mechanism underlying these clinical findings has remained elusive. Here we show that the human fetal adrenal cortex synthesized cortisol much earlier than previously documented, an effect associated with transient expression of the orphan nuclear receptor nerve growth factor IB-like (NGFI-B) and its regulatory target, the steroidogenic enzyme type 2 3ß-hydroxysteroid dehydrogenase (HSD3B2). This cortisol biosynthesis was maximal at 8–9 wpc under the regulation of ACTH. Negative feedback was apparent at the anterior pituitary corticotrophs. ACTH also stimulated the adrenal gland to secrete androstenedione and testosterone. In concert, these data promote a distinctive mechanism for normal human development whereby cortisol production, determined by transient NGFI-B and HSD3B2 expression, provides feedback at the anterior pituitary to modulate androgen biosynthesis and safeguard normal female sexual differentiation

Topics: QH301
Year: 2006
OAI identifier: oai:eprints.soton.ac.uk:27072
Provided by: e-Prints Soton

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.